The health care industry in Brazil is one of the industries that is growing at an unprecedented rate and promises great investment opportunities. The Brazilian government is making sustainable efforts to revamp the prevailing healthcare system in the country, with a view to achieve greater efficiency.
The government is also making constant efforts to restructure the health industry in Brazil by inducing application of state-of-the-art Information Technology systems. The health industry in Brazil is the biggest in the South American continent and holds immense potential for further expansion.
The Brazil government’s ambitious plans to expand the health care industry provide ample investment opportunities for foreign investors. Investment opportunity lies in supplying medical equipment and IT products. Foreign investors can invest in providing patient monitoring services.
To attract foreign investment in the country the Brazilian government has taken the initiative and has taken measures to introduce reformatory plans to restructure the healthcare delivery system. The government of Brazil has decentralized the health care sector in every Brazilian state and given them the autonomy.
The Pharmaceutical industry, which is a part of the Health Industry, holds great potential for investment in Brazil. The country is being tipped as being one of the top seven countries in the world that has tremendous potential for growth in the pharmaceutical sector and is regarded as being the emerging market for investment.
In terms of the revenue generated, the Brazilian Pharmaceutical industry is the 10th largest market in the world and is the second largest market in South America. The pharmaceutical industry is huge, and is responsible for providing employment for about 47,000 people in Brazil.
The Brazilian Pharmaceutical industry is one of the main industries that are the central point of the Brazilian government’s industrial policy. The government of Brazil, with a view to give a boost to the industry, has formulated a special financing program. The government aims to increase the local production of medicines, facilitate development of Research and Development centers and encourage mergers and alliances with foreign investors.
The main motto of the Brazil government is to bring down the negative balance of trade of pharmaceuticals, improve the standards of drug quality in the country and enhance production of medicines. The government of Brazil has very ambitious plans of creating an environment in the country to attract investment of about $5 billion dollars. Thus, there is great opportunity for investors to invest in the sector and gain valuable returns on their investments.
In the past, the pharmaceutical manufacturing companies in Brazil lacked proper production technique. Also, the government imposed heavy taxes on medicines. As a result, not many local investors were keen to invest in the sector. However, the situation today has changed drastically. The government now has reduced the prices of drugs and this has created a dynamic investment environment in the country.
The Brazilian government today actively encourages new investors in the sector by providing them the option of preferential purchase in public tenders. The government also offers special financial investment conditions, which are beneficial for the investors.
Thus, with the backing of the government, the investors can gain tremendous advantage from investing in the health industry of Brazil.